Journey Medical Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -43.1% | -142.5% | – | – | -274.2% | – | |
| – | +53.2% | +70.8% | +175.6% | +63.7% | +127.7% | +19.9% | +68.9% | +70.5% | -11.7% | -8.8% | +23.6% | |
| – | +212.4% | +114.4% | +88.2% | +44.1% | -99.2% | -36.3% | +1,511.8% | +79.4% | -41.1% | +134.0% | +3.1% | |
| – | – | – | – | – | – | -14.9% | +3,788.8% | – | – | – | – | |
| – | – | -41.0% | +250.8% | -176.3% | – | -164.4% | – | -57.9% | -126.7% | – | – | |
| – | +29.5% | +272.8% | -63.1% | +121.6% | +289.6% | -50.0% | +733.3% | +100.0% | -75.0% | +200.0% | -100.0% | |
| – | -97.6% | +4,905.3% | -19.8% | -87.3% | -81.9% | -50.0% | +733.3% | +100.0% | -75.0% | +200.0% | – | |
| – | – | – | – | – | – | – | – | -76.1% | – | – | – | |
| – | -38.2% | +32.3% | +32.6% | -98.8% | – | – | – | -76.1% | – | – | – | |
| – | – | – | – | – | – | -85.9% | – | +234.5% | -126.4% | – | -5.4% | |
| – | -40.9% | +35.0% | +232.9% | -92.4% | -110.0% | -86.3% | – | -69.0% | -129.2% | – | -4.5% | |
| – | +368.7% | -226.1% | – | -175.1% | – | +12.3% | +1,085.3% | -141.8% | – | – | – | |
| – | – | – | – | – | – | -40.6% | -409.8% | – | – | -10,152.9% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.